Cratoxylum formosum Extract Protects against Amyloid-Beta Toxicity in a Caenorhabditis elegans Model of Alzheimer's Disease

Planta Medica

Volumn 82, Issue 6, 2016, Pages 516-523

  Keowkase, Roongpetch ^a   Weerapreeyakul, Natthida ^b  

^a SRINAKHARINWIROT UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Alzheimer's disease; amyloid ; Caenorhabditis elegans; Cratoxylum formosum ssp. pruniflorum; Guttiferae

Indexed keywords

AMYLOID BETA PROTEIN; ASCORBIC ACID; CAFFEIC ACID; CHLOROGENIC ACID; CRATOXYLUM FORMOSUM EXTRACT; GALLIC ACID; GINKGO BILOBA EXTRACT; HEAT SHOCK TRANSCRIPTION FACTOR 1; HYDROGEN PEROXIDE; JUGLONE; NEUROPROTECTIVE AGENT; PLANT EXTRACT; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; ANTIOXIDANT; CAENORHABDITIS ELEGANS PROTEIN; DAF-16 PROTEIN, C ELEGANS; DNA BINDING PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; HEAT SHOCK FACTOR-1, C ELEGANS; NAPHTHOQUINONE; PROTECTIVE AGENT; SKN-1 PROTEIN, C ELEGANS; TRANSCRIPTION FACTOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CAENORHABDITIS ELEGANS; CELL STRESS; CONTROLLED STUDY; CRATOXYLUM FORMOSUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARALYSIS; PLANT STEM; PLANT TWIG; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SURVIVAL; TEMPERATURE STRESS; TRANSGENIC ANIMAL; ANIMAL; CHEMISTRY; CLUSIACEAE; DISEASE MODEL; DRUG EFFECTS; GENETICS; METABOLISM;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIOXIDANTS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CLUSIACEAE; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FORKHEAD TRANSCRIPTION FACTORS; NAPHTHOQUINONES; OXIDATIVE STRESS; PARALYSIS; PLANT EXTRACTS; PROTECTIVE AGENTS; TRANSCRIPTION FACTORS;

EID: 84957705999     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0041-111621     Document Type: Article

References (66)

1. Querfurth H. W., LaFerla F. M. Alzheimer's disease. N Engl J Med: 2010; 362 329 344
2. Blennow K., de Leon M. J., Zetterberg H. Alzheimer's disease. Lancet: 2006; 368 387 403
3. Cummings J. L. Alzheimer's disease. N Engl J Med: 2004; 351 56 67
4. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci: 1997; 20 154 159
5. Tanzi R. E., Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell: 2005; 120 545 555
6. Butterfield D. A., Drake J., Pocernich C., Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol Med: 2001; 7 548 554
7. Götz J., Ittner L. M. Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci: 2008; 9 532 544
8. Strange K. An overview of C. elegans biology. Methods Mol Biol: 2006; 351 1 11
9. Pierce S. B., Costa M., Wisotzkey R., Devadhar S., Homburger S. A., Buchman A. R., Ferguson K. C., Heller J., Platt D. M., Pasquinelli A. A., Liu L. X., Doberstein S. K., Ruvkun G. Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family. Genes Dev: 2001; 15 672 686
10. Ashrafi K., Chang F. Y., Watts J. L., Fraser A. G., Kamath R. S., Ahringer J., Ruvkun G. Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature: 2003; 421 268 272
11. Bergamaschi D., Samuels Y., O'Neil N. J., Trigiante G., Crook T., Hsieh J. K., O'Connor D. J., Zhong S., Campargue I., Tomlinson M. L., Kuwabara P. E., Lu X. iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat Genet: 2003; 33 162 167
12. Link C. D. Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci U S A: 1995; 92 9368 9372
13. Link C. D. Transgenic invertebrate models of age-associated neurodegenerative diseases. Mech Ageing Dev: 2001; 122 1639 1649
14. Nass R., Hall D. H., Miller D. M. 3rd, Blakely R. D. Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans. Proc Natl Acad Sci U S A: 2002; 99 3264 3269
15. Lakso M., Vartiainen S., Moilanen A. M., Sirvio J., Thomas J. H., Nass R., Blakely R. D., Wong G. Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein. J Neurochem: 2003; 86 165 172
16. Faber P. W., Alter J. R., MacDonald M. E., Hart A. C. Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. Proc Natl Acad Sci U S A: 1999; 96 179 184
17. Wu Y., Smith J. V., Paramasivam V. Ginkgo biloba extract EGb 761 increases stress resistance and extends life span of Caenorhabditis elegans. Cell Mol Biol: 2002; 48 725 731
18. Saul N., Pietsch K., Menzel R., Steinberg C. E. Quercetine-mediated longevity in Caenorhabditis elegans: is DAF-16 involved. Mech Ageing Dev: 2008; 129 611 613
19. Yu Y. B., Dosanjh L., Lao L., Tan M., Shim B. S., Luo Y. Cinnamomum cassia bark in two herbal formular increase life span in Caenorhabditis elegans via insulin signaling and stress response pathways. PLoS One: 2010; 5 e9339
20. Canuelo A., Gilbert-Lopez B., Pacheco-Linan P., Martinez-Lara E., Siles E., Miranda-Vizuete A. Tyrosol, a main phenol present in extra virgin olive oil, increases lifespan and stress resistance in Caenorhabditis elegans. Mech Ageing Dev: 2012; 133 563 574
21. Chen W., Rezaizadehnajafi L., Wink M. Influence of resveratrol on oxidative stress resistance and life span in Caenorhabditis elegans. J Pharm Pharmacol: 2013; 65 682 688
22. Link C. D. Invertebrate models of Alzheimer's disease. Genes Brain Behav: 2005; 4 147 156
23. Link C. D. C. elegans models of age-associated neurodegenerative diseases: lessons from transgenic worm models of Alzheimer's disease. Exp Gerontol: 2006; 41 1007 1013
24. Yatin S. M., Varadarajan S., Link C. D., Butterfield D. A. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42). Neurobiol Aging: 1999; 20 325 330 discussion 339-342
25. Drake J., Link C. D., Butterfield D. A. Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model. Neurobiol Aging: 2003; 24 415 420
26. Selkoe D. J. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev: 2001; 81 741 766
27. Butterfield D. A., Howard B., Yatin S., Koppal T., Drake J., Hensley K., Aksenov M., Aksenova M., Subramaniam R., Varadarajan S., Harris-White M. E., Pedigo N. W., Carney J. M. Elevated oxidative stress in models of normal brain aging and Alzheimer's disease. Life Sci: 1999; 65 1883 1892
28. Wu Y., Wu Z., Butko P., Christen Y., Lambert M. P., Klein W. L., Link C. D., Luo Y. Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. J Neurosci: 2006; 26 13102 13113
29. Tchantchou F., Xu Y., Wu Y., Christen Y., Luo Y. EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer's disease. FASEB J: 2007; 21 2400 2408
30. Smith J. V., Luo Y. Studies on molecular mechanisms of Ginkgo biloba extract. Appl Microbiol Biotechnol: 2004; 64 465 472
31. Smith J. V., Luo Y. Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761. J Alzheimers Dis: 2003; 5 287 300
32. Lim G. P., Chu T., Yang F., Beech W., Frautschy S. A., Cole G. M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci: 2001; 21 8370 8377
33. Srithi K., Balslev H., Wangpakapattanawong P., Srisanga P., Trisonthi C. Medicinal plant knowledge and its erosion among the Mien (Yao) in northern Thailand. J Ethnopharmacol: 2009; 123 335 342
34. Nonpunya A., Weerapreeyakul N., Barusrux S. Cratoxylum formosum (Jack) Dyer ssp. pruniflorum (Kurz) Gogel. (Hong ya mu) extract induces apoptosis in human hepatocellular carcinoma HepG2 cells through caspase-dependent pathways. Chin Med: 2014; 9 12
35. Kukongviriyapan U., Luangaram S., Leekhaosoong K., Kukongviriyapan V., Preeprame S. Antioxidant and vascular protective activities of Cratoxylum formosum, Syzygium gratum and Limnophila aromatica. Biol Pharm Bull: 2007; 30 661 666
36. Boonsri S., Karalai C., Ponglimanont C., Kanjana-opas A., Chantrapromma K. Antibacterial and cytotoxic xanthones from the roots of Cratoxylum formosum. Phytochemistry: 2006; 67 723 727
37. Sripanidkulchai K., Teepsawang S., Sripanidkulchai B. Protective effect of Cratoxylum formosum extract against acid/alcohol-induced gastric mucosal damage in rats. J Med Food: 2010; 13 1097 1103
38. Maisuthisakul P., Pongsawatmanit R., Gordon M. H. Antioxidant properties of Teaw (Cratoxylum formosum Dyer) extract in soybean oil and emulsions. J Agric Food Chem: 2006; 54 2719 2725
39. Duan Y. H., Dai Y., Wang G. H., Zhang X., Chen H. F., Chen J. B., Yao X. S., Zhang X. K. Bioactive xanthones from the stems of Cratoxylum formosum ssp. pruniflorum. J Nat Prod: 2010; 73 1283 1287
40. Boonnak N., Karalai C., Chantrapromma S., Ponglimanont C., Kanjana-Opas A., Chantrapromma K., Kato S. Chromene and prenylated xanthones from the roots of Cratoxylum formosum ssp. pruniflorum. Chem Pharm Bull (Tokyo): 2010; 58 386 389
41. Koceva-Chyla A., Jedrzejczak M., Skierski J., Kania K., Jozwiak Z. Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: relation to drug cytotoxicity and caspase-3 activation. Apoptosis: 2005; 10 1497 1514
42. Prayong P., Barusrux S., Weerapreeyakul N. Cytotoxic activity screening of some indigenous Thai plants. Fitoterapia: 2008; 79 598 601
43. Sangha J. S., Sun X., Wally O. SD, Zhang K., Ji X., Wang Z., Wang Y., Zidichouski J., Prithiviraj B., Zhang J. Liuwei Dihuang (LWDH), a traditional chinese medicinal formula, protects against β -amyloid toxicity in transgenic Caenorhabditis elegans. PLoS One: 2012; 7 e43990
44. Cohen E., Bieschke J., Perciavalle R. M., Kelly J. W., Dillin A. Opposing activities protect against age-onset proteotoxicity. Science: 2006; 313 1604 1610
45. Cohen E., Dillin A. The insulin paradox: aging, proteotoxicity and neurodegeneration. Nat Rev Neurosci: 2008; 9 759 767
46. Cohen E., Paulsson J. F., Blinder P., Burstyn-Cohen T., Du D., Estepa G., Adame A., Pham H. M., Holzenberger M., Kelly J. W., Masliah E., Dillin A. Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. Cell: 2009; 139 1157 1169
47. Przybysz A. J., Choe K. P., Roberts L. J., Strange K. Increased age reduces DAF-16 and SKN-1 signaling and the hormetic response of Caenorhabditis elegans to the xenobiotic juglone. Mech Ageing Dev: 2009; 130 357 369
48. Sykiotis G. P., Bohmann D. Stress-activated cap'n'collar transcription factors in aging and human disease. Sci Signal: 2010; 3 re3
49. Strayer A., Wu Z., Christen Y., Link C. D., Luo Y. Expression of the small heat-shock protein Hsp-16.2 in Caenorhabditis elegans is suppressed by Ginkgo biloba extract EGb 761. FASEB J: 2003; 17 2305 2307
50. Kaletta T., Hengartner M. O. Finding function in novel targets: C. elegans as a model organism. Nat Rev Drug Discov: 2006; 5 387 398
51. Link P., Wetterauer B., Fu Y., Wink M. Extracts of Glycyrrhiza uralensis and isoliquiritigenin counteract amyloid- β toxicity in Caenorhabditis elegans. Planta Med: 2015; 81 357 362
52. Abbas S., Wink M. Epigallocatechin gallate from green tea (Camellia sinensis) increases lifespan and stess resistance in Caenorhabditis elegans. Planta Med: 2009; 75 216 221
53. Sunagawa T., Shimizu T., Kanda T., Tagashira M., Sami M., Shirasana T. Procyanidins from apples (Malus pumila Mill.) extend the lifespan of Caenorhabditis elegans. Planta Med: 2011; 77 122 127
54. Dostal V., Christine M. R., Link C. D. Genetic mechanisms of coffee extract protection in a Caenorhabditis elegans model of β -amyloid peptide toxicity. Genetics: 2010; 186 857 866
55. An J. H., Blackwell T. K. SKN-1 links C. elegans mesendodermal specification to a conserved oxidative stress response. Genes Dev: 2003; 17 1882 1893
56. Osbum W. O., Kensler T. W. Nrf2 signaling: an adaptive response pathway for protection against environmental toxic results. Mutat Res: 2008; 659 31 39
57. Kanninen K., Heikkinen R., Malm T., Rolova T., Kuhmonen S. Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A: 2009; 106 16505 16510
58. Wruck C. J., Gotz M. E., Herdegen T., Varoga D., Brandenburg L. O. Kavalactones protect neural cells against amyloid beta peptide-induced neurotoxicity via extracellular signal-regulated kinase 1/2-dependent nuclear factor erythroid 2-related factor 2 activation. Mol Pharmacol: 2008; 73 1785 1795
59. Alali F. Q., Tawaha K., El-Elimat T., Syouf M., El-Fayad M., Abulaila K., Nielsen S. J., Wheaton W. D., Falkinham J. O. 3rd, Oberlies N. H. Antioxidant activity and total phenolic content of aqueous and methanolic extracts of Jordanian plants: an ICBG project. Nat Prod Res: 2007; 21 1121 1131
60. Tawaha K., Alali F. Q., Gharaibeh M., Mohammad M., El-Elimat T. Antioxidant activity and total phenolic content of selected Jordanian plant species. Food Chem: 2007; 104 1372 1378
61. Shukla V., Mishra S. K., Pant H. L. Oxidative stress in neurodegeneration. Adv Pharmacol Sci: 2011; 572634
62. Larsen P. L. Aging and resistance to oxidative damage in Caenorhabditis elegans. Proc Natl Acad Sci U S A: 1993; 90 8905 8909
63. Rogalla T., Ehrnsperger M., Preville X., Kotlyarov A., Lutsch G., Ducasse C., Paul C., Wieske M., Arrigo A. P., Buchner J., Gaestel M. Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation. J Biol Chem: 1999; 274 18947 18956
64. Morimoto R. I. The heat shock response: systems biology of proteotoxic stress in aging and disease. Cold Spring Harb Symp Quant Biol: 2011; 76 91 99
65. Kourtis N. Small heat-shock protein protect from heat-stroke-associated neurodegeneration. Nature: 2012; 490 213 218
66. Prayong P., Weerepreeyakul N., Sripanidkulchai B. Validation of isocratic eluting and stepwise flow rate gradient for HPLC determination of catechins, gallic acid and caffeine in tea. Sci Asia: 2007; 33 113 117